Tag: CBT > Cannabis Rescheduling: Page 10

Interviews & Opinion

A Positive Sign For Schedule III

In Vienna, a U.S. state department legal adviser champions member-state discretion over domestic drug policy, potentially removing the obstacle the Single Convention drug treaty could pose to cannabis reform.

November 7, 2023

Cannabis Rescheduling

31 Bipartisan House Lawmakers Urge DEA to End ‘Failed’ Cannabis Prohibition

A group of U.S. representatives sent a letter to DEA Administrator Anne Milgram calling on her agency to “recognize the merits of full descheduling.”

November 1, 2023

Cannabis Rescheduling

CBT Receives Heavily Redacted HHS Letter to DEA on Cannabis Reclassification

Cannabis Business Times has filed multiple Freedom of Information Act requests to obtain the letter, which only Bloomberg News has reported viewing, in an effort to confirm HHS recommended reclassifying cannabis to Schedule III.

October 27, 2023

Cannabis Tax Law

280E: How the Cannabis Industry Got Here

As cannabis businesses brace for potential tax relief should the plant be rescheduled, a look at the origins of IRC Section 280E and why it applies to legal, state-level cannabis companies.

October 18, 2023

Cannabis Rescheduling

Rescheduling Cannabis: Would 1961 Drug Treaty Be a Possible Wrench?

Reclassifying cannabis to a Schedule III drug would put the U.S. in noncompliance with the international treaty Single Convention on Narcotic Drugs, 1961. Will this create a barrier for the U.S. in its scheduling review, and if so, to what extent? Historian James H. Mills weighs in.

October 5, 2023

Cannabis Rescheduling

‘There Will Be Wind in Our Sails’

September 26, 2023

Cannabis Rescheduling

‘Descheduling Would Not Be Utopia’

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

September 26, 2023

Interviews & Opinion

Opinion: HHS Rescheduling Recommendation is 'About Damn Time'

The U.S. Department of Health and Human Services recognition that cannabis should no longer be classified in the same category as heroin is an event to be celebrated. But the trajectory of U.S. policy deserves to be mourned.

September 20, 2023

Cannabis Rescheduling

'Descheduling Would Not Be Utopia'

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

September 13, 2023

Cannabis Industry Research

The Impacts of Cannabis Rescheduling: Panelists Weigh In During International Cannabis Bar Association Webinar

Industry legal experts Khurshid Khoja, Amber Littlejohn and Shane Pennington shared insight into what rescheduling could mean for taxes, research and federal enforcement.

September 12, 2023

Colorado

Colorado Governor to President Biden: ‘We Must Do Better’ on Federal Cannabis Reform

Gov. Jared Polis encouraged the president to move swiftly to reschedule cannabis and urged him to not let up on other incremental changes.

September 5, 2023

Cannabis Rescheduling

‘Rescheduling is Not Enough,’ And Other Reactions to HHS Recommendation on Cannabis

Cannabis industry responds with cautious optimism to the Department of Health and Human Services' call to reschedule the plant, noting the significance of the announcement but also the potential limitations of the move.

September 5, 2023